Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. - Hwu,W.J.; Krown,S.E.; Menell,J.H.; Panageas,K.S.; Merrell,J.; Lamb,L.A.; Williams,L.J.; Quinn,C.J.; Foster,T.; Chapman,P.B.; Livingston,P.O.; Wolchok,J.D.; et al. (J Clin Oncol, 2003)